Walter Zieglgänsberger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Walter Zieglgänsberger has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Achim Berthele
1 shared publicationC Rewerts
Department of Psychiatry, Ludwig Maximilian University, Munich, Germany
1 shared publicationS. C. Azad
Klinikum Großhadern, Ludwig-Maximilians-Universität München
1 shared publicationThomas R. Tölle
1 shared publicationW Zieglgänsberger
Max Planck Institute of Psychiatry, Munich
1 shared publication
Latest Publications
- 1 January 2012
- Published by Springer Nature
- p. 383-390
Schmerz
- 1 April 2005
- Published by Cambridge University Press (CUP) in CNS Spectrums
- Vol. 10 (4) , 298-308
Understanding Neuropathic Pain
Neuropathic pain is defined as a chronic pain condition that occurs or persists after a primary lesion or dysfunction of the peripheral or central nervous system. Traumatic injury of peripheral nerves also increases the excitability of nociceptors in and around nerve trunks and involves components released from nerve terminals (neurogenic inflammation) and immunological and vascular components from cells resident within or recruited into the affected area. Action potentials generated in nociceptors and injured nerve fibers release excitatory neurotransmitters at their synaptic terminals such as L-glutamate and substance P and trigger cellular events in the central nervous system that extend over different time frames. Short-term alterations of neuronal excitability, reflected for example in rapid changes of neuronal discharge activity, are sensitive to conventional analgesics, and do not commonly involve alterations in activity-dependent gene expression. Novel compounds and new regimens for drug treatment to influence activity-dependent long-term changes in pain transducing and suppressive systems (pain matrix) are emerging.
- 1 April 2005
- Published by Cambridge University Press (CUP) in CNS Spectrums
- Vol. 10 (4) , 298-308
Understanding Neuropathic Pain
Neuropathic pain is defined as a chronic pain condition that occurs or persists after a primary lesion or dysfunction of the peripheral or central nervous system. Traumatic injury of peripheral nerves also increases the excitability of nociceptors in and around nerve trunks and involves components released from nerve terminals (neurogenic inflammation) and immunological and vascular components from cells resident within or recruited into the affected area. Action potentials generated in nociceptors and injured nerve fibers release excitatory neurotransmitters at their synaptic terminals such as L-glutamate and substance P and trigger cellular events in the central nervous system that extend over different time frames. Short-term alterations of neuronal excitability, reflected for example in rapid changes of neuronal discharge activity, are sensitive to conventional analgesics, and do not commonly involve alterations in activity-dependent gene expression. Novel compounds and new regimens for drug treatment to influence activity-dependent long-term changes in pain transducing and suppressive systems (pain matrix) are emerging.
- 1 June 2004
- Published by Taylor & Francis in Scandinavian Journal of Rheumatology
- Vol. 33 (sup119) , 19-23
Analgesic effects of 5‐HT3receptor antagonists
Current research suggests an involvement of 5‐HT3 receptors in peripheral and central perception and processing of pain as well as in inflammation. Tropisetron and other selective 5‐HT3 receptor antagonists have been used successfully for pain reduction and treatment of related symptoms in patients diagnosed with fibromyalgia. This article proposes a concept of the underlying pathophysiology and mechanisms of action of 5‐HT3 receptor antagonists in the context of the relevant clinical data on their application in patients with rheumatic disease.
- 1 June 2004
- Published by Taylor & Francis in Scandinavian Journal of Rheumatology
- Vol. 33 (sup119) , 19-23
Analgesic effects of 5‐HT3receptor antagonists
Current research suggests an involvement of 5‐HT3 receptors in peripheral and central perception and processing of pain as well as in inflammation. Tropisetron and other selective 5‐HT3 receptor antagonists have been used successfully for pain reduction and treatment of related symptoms in patients diagnosed with fibromyalgia. This article proposes a concept of the underlying pathophysiology and mechanisms of action of 5‐HT3 receptor antagonists in the context of the relevant clinical data on their application in patients with rheumatic disease.
- 1 December 2003
- Published by Springer Nature in Der Schmerz
- Vol. 17 (6) , 441-444
Was wissen wir ber die Chronifizierung von Schmerz?
- 1 December 2003
- Published by Springer Nature in Der Schmerz
- Vol. 17 (6) , 441-444
Was wissen wir ber die Chronifizierung von Schmerz?